NCT00231920 Inactivated Influenza Vaccine in Infants 10-22 Weeks of Age Status COMPLETED Phase PHASE1
NCT00231907 A Phase I Safety and Immunogenicity Study of Mix and Match of Licensed Flu Vaccine and Flumist Status COMPLETED Phase PHASE1
NCT00221676 Effectiveness of Influenza Vaccination Among General Practitioners Status COMPLETED Phase PHASE4
NCT00217230 Trial To Assess Safety And Efficacy Of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T) In Adults Aged 60 Years And Older Status COMPLETED Phase PHASE3
NCT00216242 Study of the Protective Effect of an Injectable Influenza Vaccine Against Influenza Illness in Adults Under 50 y.o. Status UNKNOWN Phase PHASE3
NCT00213967 The Effect of Needle Temperature on Pain Ratings Following Intramuscular Injection Status COMPLETED Phase NA
NCT00197301 Liposomal Based Intranasal Influenza Vaccine:Safety and Efficacy Status COMPLETED Phase PHASE1/PHASE2
NCT00197288 Study Comparing the Immune Response of Fluarix and Fluzone Influenza Vaccines Status COMPLETED Phase PHASE3
NCT00197223 Post-marketing Study to Evaluate the Efficacy of Influenza Vaccine Status COMPLETED Phase PHASE3
NCT00192491 Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy Children Status COMPLETED Phase PHASE3
NCT00192426 Trial to Evaluate the Immune Response to OPV When Administered Concomitantly With CAIV-T to Healthy Children. Status COMPLETED Phase PHASE3
NCT00192413 Trial to Compare the Safety, Tolerability, and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Inactivated, Influenza Vaccine, Trivalent, Types A & B, in Adults Aged 60 Years and Older Against Culture-confirmed Influenza Status COMPLETED Phase PHASE3
NCT00192387 Trial to Investigate Viral Shedding in Healthy Children Vaccinated With Vaccine Virus Liquid (CAIV-T) Status COMPLETED Phase PHASE2
NCT00192361 Trial of the Safety, Transmissibility, and Phenotypic and Genotypic Stability of Influenza Virus Vaccine,(CAIV-T), in Children Who Attend Day Care. (Final Report Version 2.0) Status COMPLETED Phase PHASE3
NCT00192322 Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine (CAIV-T) in Healthy Children Status COMPLETED Phase PHASE2
NCT00192309 Phase II Study to Investigate the Kinetics of the Immune Response Generated by Influenza Virus Vaccine. Status COMPLETED Phase PHASE2
NCT00192283 Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold- Adapted (CAIV-T) in Healthy Children Attending Day Care Centers Status COMPLETED Phase PHASE3
NCT00192231 Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine,(CAIV-T) Status COMPLETED Phase PHASE3